Biotech platforms are out, products are back in (baybridgebio.com)

maybe not even true, but he writes a decent article

“I wish I majored in biology and CS and got a PhD” says the author. So do your readers and investors. This investor skill mismatch is a huge problem in biotech and a major reason for the COVID boost and recent crash.